MAP kinase regulation of cell-fate transitions in yeast
MAP 激酶对酵母细胞命运转变的调节
基本信息
- 批准号:7995234
- 负责人:
- 金额:$ 30.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAttenuatedBindingBioinformaticsBiologicalCell Fate ControlCell physiologyCellsCommitComputer SimulationDNADataData SetDevelopmentDiseaseDoseFeedbackGene ExpressionGenesGeneticGenetic ModelsGenetic ProgrammingGenetic TranscriptionGlobal ChangeGrowthHealthHepatocyteHomeostasisHormonesHumanImageIndividualInflammatoryLabelLeadLearningLifeLocationMalignant NeoplasmsMapsMeasurementMediatingMessenger RNAMetabolic DiseasesMethodologyMicroarray AnalysisMicrofluidic MicrochipsMitogen-Activated Protein KinasesModelingMolecularMolecular ProfilingMonitorMutationNon-Insulin-Dependent Diabetes MellitusOrganismOutcomePartner in relationshipPathogenesisPathway interactionsPatternPheromonePhysiologicalPlant RootsProteinsProteomicsRNARegulationRegulatory PathwayRelative (related person)ResistanceRoleSaccharomyces cerevisiaeSaccharomycetalesSignal PathwaySignal TransductionSpecific qualifier valueStimulusSystemTestingTimeTo specifyTranscription Repressor/CorepressorTranslatingValidationVariantYeastsbasebone cellbrain cellcell typecellular developmentdosagegenetic manipulationgenome-wideinsightinterdisciplinary approachmathematical modelmodel developmentmutantprogramspromoterresponsetime intervaltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Mechanisms that coordinate transcriptional programs in response to specific stimuli are central to understanding normal development and homeostasis. The pheromone-induced transition of budding yeast to either a chemotrophic or mating competent form is a model for dissecting the molecular basis of this regulation. A single mitogen activated protein kinase (MAPK) cascade mediates both transitions. This pathway utilizes two MAPKs, Fus3 and Kss1, that both negatively and positively regulate activity of the Ste12 and Tec1 transcriptional regulators. Ste12 is essential for the changes in gene expression that underlie establishment of both fates while Tec1 is important only for the chemotrophic fate. The genetic program for the chemotrophic fate transition induced by low pheromone concentration is still undefined. Fus3 and Kss1 activation profiles are differentially affected at high vs. low pheromone. We hypothesize that the dose-dependent differences in their activation and their antagonistic regulatory roles control Ste12 and Tec1 activity and degradation in a manner that prepares cells for one or the other differentiation program. We propose a multidisciplinary approach to compare the regulatory networks for the two fates and the molecular basis of the developmental switch: Aim 1. Define the global expression program for chemotrophic growth using microarray technology and compare it to that for mating differentiation. Bioinformatic approaches are proposed to delineate the physiological and phenotypic signatures and regulatory networks that distinguish the two programs. Aim 2. a and b) Combine experimental analyses with computational modeling to quantify the relative contributions from positive and negative regulation by Fus3 and Kss1 and the temporal control of transcription factor degradation on mediating the switch between alternative programs. Empirical measurements of transcription factor abundance and representative mRNAs in wild-type and mutant backgrounds that perturb regulation will be used to test the underlying hypotheses of the model. c) Time-lapse imaging under different pheromone induction regimes will be used to test whether a pheromone gradient reinforces feedback loops that regulate fluctuations and thereby reduce variability in pathway activity and fate determination. Our understanding of the pheromone induced MAPK pathway and the ease of genetic manipulations available with yeast allow discernment of how differences in the amplitude and timing of MAPK activation translate into different transcriptional patterns. Because of the conservation of MAPK pathways, the regulatory paradigms defined here will apply to different MAPK mediated signaling pathways in humans that are at the root of the pathogenesis of hormone dependent cancers, inflammatory diseases, and metabolic disorders. PUBLIC HEALTH RELEVANCE Mitogen activated protein kinase (MAPK) pathways control normal cellular development and function. Differences in the amplitude and timing of MAPK activation are known to affect whether cells divide and multiply or develop into a specialized cell types, such as liver, bone, or brain cells. This proposal exploits advantages of studies with the model genetic organism, S. cerevisiae, to define the molecular mechanisms that translate different patterns of MAPK activation into different developmental fates. The findings will give us a better understanding of how aberrant regulation of these pathways in humans leads to hormone dependent cancers, inflammatory diseases, and metabolic disorders such as Type II diabetes.
描述(由申请人提供):协调转录程序以响应特定刺激的机制是理解正常发育和动态平衡的核心。信息素诱导的萌芽酵母向营养或交配能力形式的转变是剖析这一调控的分子基础的一个模型。单一的丝裂原活化蛋白激酶(MAPK)级联介导了这两种转变。该途径利用两个MAPK,Fus3和Kss1,负向和正向调节STE12和Tec1转录调节因子的活性。STE12对于决定这两种命运的基因表达变化是必不可少的,而Tec1只对化学营养命运重要。低信息素浓度诱导的趋化命运转移的遗传程序尚不清楚。Fus3和Kss1的激活谱在高信息素和低信息素时受到不同的影响。我们假设,STE12和Tec1的激活及其拮抗调节作用的剂量依赖性差异控制着STE12和Tec1的活性和降解,从而为细胞的一个或另一个分化程序做好准备。我们提出了一种多学科的方法来比较这两种命运的调控网络和发育开关的分子基础:目的1.利用微阵列技术定义趋化生长的全球表达程序,并将其与交配分化的表达程序进行比较。生物信息学方法被提出来描述区分这两个程序的生理和表型特征以及调控网络。目的2.a和b)将实验分析和计算模型相结合,以量化Fus3和Kss 1的正负调控以及转录因子降解的时间控制在调节可选程序之间的切换方面的相对贡献。对转录因子丰度和野生型和突变型背景中干扰调控的代表性mRNAs的经验测量将用于检验该模型的基本假设。C)将使用不同信息素诱导机制下的延时成像来测试信息素梯度是否加强了调节波动的反馈环,从而减少了途径活动和命运确定的可变性。我们对信息素诱导的MAPK途径的理解以及酵母可用的遗传操作的简便性使我们能够辨别MAPK激活的幅度和时间的差异如何转化为不同的转录模式。由于MAPK通路的保守性,这里定义的调控范式将适用于人类中不同的MAPK介导的信号通路,这些通路是激素依赖型癌症、炎症性疾病和代谢紊乱发病的根源。与公共健康相关的丝裂原活化蛋白激酶(MAPK)通路控制着正常的细胞发育和功能。众所周知,MAPK激活的幅度和时间的不同会影响细胞的分裂和增殖,或者发展成一种特殊的细胞类型,如肝、骨或脑细胞。这一建议利用对模式遗传有机体酿酒酵母的研究优势,来确定将不同的MAPK激活模式转化为不同的发育命运的分子机制。这些发现将使我们更好地理解这些途径在人类中的异常调节如何导致激素依赖型癌症、炎症性疾病和代谢紊乱,如II型糖尿病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BEVERLY ERREDE其他文献
BEVERLY ERREDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BEVERLY ERREDE', 18)}}的其他基金
MAP kinase regulation of cell-fate transitions in yeast
MAP 激酶对酵母细胞命运转变的调节
- 批准号:
8079935 - 财政年份:2010
- 资助金额:
$ 30.07万 - 项目类别:
MAP kinase regulation of cell-fate transitions in yeast
MAP 激酶对酵母细胞命运转变的调节
- 批准号:
8208168 - 财政年份:2009
- 资助金额:
$ 30.07万 - 项目类别:
MAP kinase regulation of cell-fate transitions in yeast
MAP 激酶对酵母细胞命运转变的调节
- 批准号:
7750028 - 财政年份:2009
- 资助金额:
$ 30.07万 - 项目类别:
Spatiotemporal modeling of signal transduction in yeast
酵母信号转导的时空模型
- 批准号:
8815612 - 财政年份:2006
- 资助金额:
$ 30.07万 - 项目类别:
Cell-fate determinants of yeast pseudohyphal growth
酵母假菌丝生长的细胞命运决定因素
- 批准号:
6599397 - 财政年份:2003
- 资助金额:
$ 30.07万 - 项目类别:
Cell-fate determinants of yeast pseudohyphal growth
酵母假菌丝生长的细胞命运决定因素
- 批准号:
6743105 - 财政年份:2003
- 资助金额:
$ 30.07万 - 项目类别:
Cell-fate determinants of yeast pseudohyphal growth
酵母假菌丝生长的细胞命运决定因素
- 批准号:
6890909 - 财政年份:2003
- 资助金额:
$ 30.07万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 30.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 30.07万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 30.07万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 30.07万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 30.07万 - 项目类别:
Idea to Innovation














{{item.name}}会员




